approval
saveDYANAVEL XR (AMPHETAMINE) — FDA approval
community read0 votes
Sponsor: TRIS PHARMA INC. Form: SUSPENSION, EXTENDED RELEASE. Route: ORAL
view source ↗Data sources
last refreshed 6mo ago
Found something off?
drug timeline · 8
- approvalAMPHETAMINE SULFATE — FDA approvalSep 26, 2025 · 420d ago
- approvalAMPHETAMINE SULFATE — FDA approvalSep 26, 2025 · 420d ago
- approvalDYANAVEL XR (AMPHETAMINE) — FDA approvalSep 23, 2025 · 423d ago
- approvalAMPHETAMINE SULFATE — FDA approvalOct 17, 2023 · 1130d ago
- approvalAMPHETAMINE SULFATE — FDA approvalOct 13, 2023 · 1134d ago
- approvalDYANAVEL XR (AMPHETAMINE) — FDA approvalJun 1, 2022 · 1633d ago
- approvalAMPHETAMINE SULFATE — FDA approvalFeb 25, 2022 · 1729d ago
- approvalDYANAVEL XR (AMPHETAMINE) — FDA approvalFeb 25, 2022 · 1729d ago
comments(0)
5-min edit window · permanent after that